A and B shall be punished by a fine of 5,000,000 won, and Defendant C shall be punished by a fine of 3,000,000 won.

The Defendants respectively.

1. Defendant A is a doctor to operate the J Council member in the Republic of Korea.

No medical person shall receive money, goods, benefits, labor, entertainment, or other economic benefits provided by a person who has obtained permission for items under Article 31 of the Pharmaceutical Affairs Act or a person who has filed a report on items for the purpose of sales promotion, such as adoption of drugs, inducement for prescription, etc.

Nevertheless, around May 2012, the Defendant received instructions from L of the K Branch of the JJ from M to the above JJ's president, and received KRW 3 million in cash provided for the purpose of sales promotion, such as adoption of and guidance for response to the Japanese medication, new-rocsium, gymsium, and so on. On January 2013, the Defendant received KRW 2 million in cash provided for the same purpose from M who received instructions from N of the K Branch of the Japanese medication.

As a result, the Defendant received economic benefits of KRW 5 million provided for the purpose of sales promotion, such as adoption and inducement of drugs as a medical person.

2. Defendant B is a doctor to operate P Council members on the O 2th floor in Hongcheon-gun.

No medical person shall receive money, goods, benefits, labor, entertainment, or other economic benefits provided by a person who has obtained permission for items under Article 31 of the Pharmaceutical Affairs Act or a person who has filed a report on items for the purpose of sales promotion, such as adoption of drugs, inducement for prescription, etc.

Nevertheless, around October 2012, the Defendant received an instruction from the K Branch of the above P, from M, for the purpose of sales promotion, such as Aroincoplass of medicine manufactured and sold in the Japanese medication from R to the K Branch of the above P, the Defendant received three million won in cash, which was provided for the purpose of sales promotion, such as adoption of and guidance for countermeasures against the Pcopian, and received two cash orders from Q, one million won in cash provided for the same purpose from the K Branch of the Japanese Pharmacopoeia and M, around April 2013 and August 2013. < Amended by Act No. 11873, Apr. 23, 2013; Act No. 11683, Aug. 2, 2013>

As a result, the defendant is a medical person.